enow.com Web Search

  1. Ads

    related to: esophoria prism correction eye drops for sale near me

Search results

  1. Results from the WOW.Com Content Network
  2. Esophoria - Wikipedia

    en.wikipedia.org/wiki/Esophoria

    Esophoria is an eye condition involving inward deviation of the eye, usually due to extra-ocular muscle imbalance. It is a type of heterophoria. Cause. Causes include: Refractive errors; Divergence insufficiency; Convergence excess; this can be due to nerve, muscle, congenital or mechanical anomalies.

  3. Prism correction - Wikipedia

    en.wikipedia.org/wiki/Prism_correction

    Prism dioptres. Prism correction is commonly specified in prism dioptres, a unit of angular measurement that is loosely related to the dioptre. Prism dioptres are represented by the Greek symbol delta (Δ) in superscript. A prism of power 1 Δ would produce 1 unit of displacement for an object held 100 units from the prism. [2]

  4. Presbyopia - Wikipedia

    en.wikipedia.org/wiki/Presbyopia

    Presbyopia is a typical part of the aging process. [4] It occurs due to age related changes in the lens (decreased elasticity and increased hardness) and ciliary muscle (decreased strength and ability to move the lens), causing the eye to focus right behind rather than on the retina when looking at close objects. [4]

  5. Exophoria - Wikipedia

    en.wikipedia.org/wiki/Exophoria

    Exophoria. Exophoria is a form of heterophoria in which there is a tendency of the eyes to deviate outward. [1] During examination, when the eyes are dissociated, the visual axes will appear to diverge away from one another. [2] The axis deviation in exophoria is usually mild compared with that of exotropia .

  6. Convergence insufficiency - Wikipedia

    en.wikipedia.org/wiki/Convergence_insufficiency

    Convergence insufficiency. Convergence Insufficiency. Other names. Convergence disorder. Specialty. Ophthalmology, optometry. Convergence insufficiency is a sensory and neuromuscular anomaly of the binocular vision system, characterized by a reduced ability of the eyes to turn towards each other, or sustain convergence .

  7. Heterophoria - Wikipedia

    en.wikipedia.org/wiki/Heterophoria

    Heterophoria is an eye condition in which the directions that the eyes are pointing at rest position, when not performing binocular fusion, are not the same as each other, or, "not straight". This condition can be esophoria, where the eyes tend to cross inward in the absence of fusion; exophoria, in which they diverge; or hyperphoria, in which ...

  8. Chronic progressive external ophthalmoplegia - Wikipedia

    en.wikipedia.org/wiki/Chronic_progressive...

    Chronic progressive external ophthalmoplegia ( CPEO) is a type of eye disorder characterized by slowly progressive inability to move the eyes and eyebrows. [1] It is often the only feature of mitochondrial disease, in which case the term CPEO may be given as the diagnosis. In other people suffering from mitochondrial disease, CPEO occurs as ...

  9. Prism cover test - Wikipedia

    en.wikipedia.org/wiki/Prism_Cover_Test

    The prism cover test ( PCT) is an objective measurement and the gold standard in measuring strabismus, i.e. ocular misalignment, or a deviation of the eye. [1] It is used by ophthalmologists and orthoptists in order to measure the vertical and horizontal deviation and includes both manifest and latent components. [1]

  10. Horror fusionis - Wikipedia

    en.wikipedia.org/wiki/Horror_fusionis

    Ophthalmology. In ophthalmology, horror fusionis is a condition in which the eyes have an unsteady deviation, with the extraocular muscles performing spasm-like movements that continuously shift the eyes away from the position in which they would be directed to the same point in space, giving rise to diplopia. Even when the double vision images ...

  11. Netarsudil - Wikipedia

    en.wikipedia.org/wiki/Netarsudil

    Netarsudil, sold under the brand name Rhopressa among others, is a medication for the treatment of glaucoma. [1] [2] [3] In the United States, in December 2017, the Food and Drug Administration (FDA) approved a 0.02% ophthalmic solution for the lowering of elevated intraocular pressure in people with open-angle glaucoma or ocular hypertension.